RAF1 and cancer: Recent study has recognized that rapidly accelerated fibrosarcoma (Raf)/mitogen‐activated protein kinase (MEK)/extracellular signal–regulated kinase (ERK) signalling pathway activation plays critical roles in cancer growth, survival and motility, as well as targeted therapy resistance mechanisms during various stages of cancer.37